Squamous cell carcinoma of the lung differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(17 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Squamous cell carcinoma of the lung}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Squamous_cell_carcinoma_of_the_lung]]
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}} {{EG}}


==Differential Diagnosis==
==Overview==
* [[Adenocarcinoma of the lung]]
Squamous cell carcinoma of the lung must be differentiated from other diseases that cause chronic [[cough]], [[weight loss]], [[hemoptysis]], and [[dyspnea]] among adults such as [[pulmonary tuberculosis]], [[sarcoidosis]], pneumonia, pulmonary [[fungal infection]], and secondary metastases.
* [[Small cell carcinoma of the lung]]
* [[Amyloidosis]]
* [[Pulmonary tuberculosis]]
* [[Non-Hodgkin's lymphoma]] (NHL)
* [[Hodgkin's lymphoma]]
* [[Thymoma]]
* Tracheal tumors
* Thyroid mass
* Arteriovenous malformation
* [[Wegener's granulomatosis]]
* [[Sarcoidosis]]
* Lung [[abscess]]<ref name="pmid22242302">{{cite journal| author=Kamiya K, Yoshizu A, Misumi Y, Hida N, Okamoto H, Yoshida S| title=[Lung abscess which needed to be distinguished from lung cancer; report of a case]. | journal=Kyobu Geka | year= 2011 | volume= 64 | issue= 13 | pages= 1204-7 | pmid=22242302 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22242302  }} </ref>
* [[Pneumonia]]
* [[Fungal infection]]
* [[Chronic eosinophilic pneumonia]]<ref name="pmid24008649">{{cite journal| author=Matsuoka T, Uematsu H, Iwakiri S, Itoi K| title=[Chronic eosinophilic pneumonia presenting as a solitary nodule, suspicious of lung cancer;report of a case]. | journal=Kyobu Geka | year= 2013 | volume= 66 | issue= 10 | pages= 941-3 | pmid=24008649 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24008649  }} </ref>


==Differentiating Squamous Cell Carcinoma of the Lung from other Diseases==
=== '''The following table summarizes the differentiation of various lung tumors based on histological and topographical features:'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref> ===
{| class="wikitable"
! colspan="11" |Abrevations:
HPV: human papillomavirus; CEA: Carcino embryogenic antigen;  TTF1: '''Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule;'''


MMP's: Mettaloprotineases matrix ;  GFAP: Glial fibrocilliary acid protein
|-
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign Lung Tumors<ref name="pmid23077446">{{cite journal |vauthors=Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK |title=Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging |journal=Radiol Oncol |volume=46 |issue=2 |pages=106–13 |date=June 2012 |pmid=23077446 |pmc=3472932 |doi=10.2478/v10019-012-0021-3 |url=}}</ref>
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign lung tumor
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cells
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="2" style="background:#DCDCDC;" align="center" + |'''[[Papilloma]]'''<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]'''
|
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* Men
* Median age of diagnosis is 54 years
|
* [[Epithelial cells]]
|
* Endobronchial
|
* Cauliflower-like lesions
* Tan-white soft to semifirm protrutions
|
* Loose fibrovascular core
* Stratified squamous epithelium
* Acanthosis
* Binucleate forms and perinuclear halos
* [[Koilocytosis]]
|
* N/A
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
* N/A
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Glandular papilloma'''
|
* Rare
* Mean age of diagnosis is 68 years
|
* [[Goblet cells]] of [[respiratory epithelium]]
|
* Endobronchial
|
* White to tan endobronchial [[Polyp|polyps]] that measure from 0.7-1.5 cm
|
* Thick arborizing stromal stalks
* Thin-walled [[blood vessels]]
* Non-ciliated or ciliated [[epithelium]]
|
* N/A
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
* N/A
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Adenom'''a<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Alveolar adenoma'''
|
* Mean age of diagnosis is 53 years
* Female predominance
|
* Alveolar [[pneumocytes]]
* Septal [[mesenchyme]]
|
* All lung lobes
* Lower lobes
* Hilar
|
* 0.7-6.0 cm
* Well demarcated smooth
* Lobulated, multicystic
* Soft to firm
* Pale yellow to tan cut surfaces
|
* Non-encapsulated
* Multicystic masses
* [[Cuboidal cells|Cuboidal cell]] linning
* Squamous metaplasia
* Myxoid and [[Collagen|collagenous]] interstitium
|
* [[Keratin]]
* [[CEA]]
* Surfactant protein
* [[TTF-1]]
* [[Actin]]
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
* N/A
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenoma'''<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
|
* Mean age of diagnosis is 32 years
* Male predominance
|
* Bronchioloalveolar cell
|
* No lobar predilection
* Involves alveolar parenchyma
|
* Well defined
* Encapsulated
* Soft, spongy to firm mass
* Granular gray white/ brown
* 1.0- 4.0 cm
|
* [[Infiltration (medical)|Infiltration]]
* [[Papillary]] growth pattern
* Fibrovascular cores
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* Cilitated and oxyphilic cells
* Occasional [[eosinophilic]] intranuclear inclusions
|
* [[Cytokeratin]]
* [[Clara cell secretory protein|Clara cell protein]]
* [[TTF-1]]
* Surfactant apoprotein
* [[CEA]]
|
* Incidental finding
|
* N/A
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma'''
|
* No sex predilection
* Mean age of diagnosis is 52 years
|
* Mucus glands of the [[bronchus]]
|
* Central
|
* White-pink to tan
* Smooth and shiny tumors
* Gelatinous mucoid solid core
* 0.7-7.5 cm
|
* Numerous [[mucin]]-filled cystic spaces
* Non-dilated microacini, glands, tubules and papillae
|
* EMA
* [[Cytokeratin|Cytokeratins]]
* [[CEA]]
|
* Coin lesion
* Air-meniscus sign
|
* N/A
|-
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]] (SCC)'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary'''
| rowspan="3" |
* Cigarette smokers
* [[Arsenic]]
| rowspan="3" |
* Epithelial cells
| rowspan="3" |
* Central
| rowspan="3" |
* White or grey lesions
* Focal carbon pigment deposits
* [[Cavitation|Cavitations]]
* Intraluminal polypoid masses
* [[Infiltration (medical)|Infiltration]]
|
* Exophytic
* Intra-epithelial 
* Without invasion
| rowspan="3" |
* [[Keratin]]
* [[Cytokeratin|Cytokeratins]]
* [[CEA]]
* [[Thyroid transcription factor-1]] ([[TTF-1]])
| rowspan="3" |
* Lobar or entire lung collapse
* Shift of the [[mediastinum]] to the ipsilateral side
* Hilar, perihilar or [[Mediastinal mass|mediastinal masses]]
| rowspan="3" |
* [[Liver]]
* [[Breast]]
* [[Bone]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell'''
|
* Cells with clear [[cytoplasm]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid'''
|
* Peripheral palisading of nuclei.
* Poor differentiation
|-
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
|
* [[Smoking]]
* [[Radon]] exposure
|
* Bronchial precursor cell
|
* Peripheral
|
* White-tan, soft, friable perihilar masses
* Extensive necrosis
* 5% peripheral coin lesions
|
* Sheet-like growth
* Nesting
* Trabeculae
* Peripheral palisading
* Rosette formation
* High mitotic rate
|
* [[CD56]]
* [[Chromogranin]]
* [[Synaptophysin]]
* [[TTF-1]]
|
* Hilar or perihilar masses
* [[Mediastinal lymphadenopathy]]
* Lobar collapse
|
* Bone marrow
* Liver
|-
| rowspan="10" style="background:#DCDCDC;" align="center" + |'''[[Adenocarcinoma]]'''<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma'''
| rowspan="10" |
* [[Smoking]]
| rowspan="10" |
* Columnar cells of bronchioles
| rowspan="10" |
* Peripheral
| rowspan="10" |
* Single or multiple lesions
* Different in size
* Peripheral distribution
* Gray-white central fibrosis
* [[Pleural]] puckering
* Anthracotic pigmentation
** [[Necrosis]]
** [[Cavitation]]
** [[Hemorrhage]]
* Lobulated or ill defined edges
|
* Irregular-shaped glands
* [[Malignant]] cells:
** Hyperchromatic nuclei
** Fibroblastic stroma
| rowspan="10" |
* Epithelial markers 
* [[CEA]]
* [[Cytokeratin|CK7]]
* [[TTF-1]]
| rowspan="10" |
* Peripheral nodules under 4.0 cm in size
* Central location as a hilar or perihilar mass
* Rarely show cavitations.
* Hilar adenopathy
* Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
| rowspan="10" |Aerogenous spread is characteristic
* Brain
* Bone
* Adrenal glands
* Liver
* Kidney
* Gastrointestinal Tract
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma'''
|
* [[Papillae]]
* [[Necrosis]]
* Surrounding invasion
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* [[Mucinous]] or non-mucinous
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous'''
|
* [[Clara cell|Clara cells]]
* [[Pneumocytes|Type II cells]]
|-
| style="background:#DCDCDC;" align="center" + |'''Mucinous'''
|
* Low grade differentiation
* Composed of:
** Tall [[Columnar epithelia|columnar cells]]
** Basal nuclei
** Pale cytoplasm resembling goblet cells
** Varying amounts of cytoplasmic mucin
* Cytologic atypia
|-
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate'''
|
* Mixed type of cells
* Low to high grade differentiated cells.
|-
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Solid adenocarcinoma with mucin production'''
| style="background:#DCDCDC;" align="center" + |'''Fetal adenocarcinoma'''
|
* Consists glandular elements:
** Tubules of [[glycogen]]-rich
** Non-ciliated cells
** Subnuclear and supranuclear [[glycogen]] [[vacuoles]]
** Rounded morules of polygonal cells with abundant [[eosinophilic]] and finely granular [[cytoplasm]]
|-
| style="background:#DCDCDC;" align="center" + |'''Mucinous (“colloid”) carcinoma'''
|
* Dissecting pools of [[mucin]] containing [[neoplastic]] cells
|-
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma'''
|
* Partial [[fibrous tissue]] capsule
* Central [[cystic]] change with [[mucin]] pooling
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
|-
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma'''
|
* Focal
* Cells with nuclei displaced to sides
* Components of other cells are present.
|-
| style="background:#DCDCDC;" align="center" + |'''Clear cell adenocarcinoma'''
|
* Clear cells with no nuclei
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid large cell carcinoma of the lung'''
| rowspan="5" |
* Approximately 10% of lung cancers
* [[Smoking]]
| rowspan="5" |
* [[Neuroendocrine cells|Neuro endocrine cells]]
* Suprabasal bronchial cells
| rowspan="5" |
* Peripheral masses
* [[Bronchi]]
| rowspan="5" |
* Soft, pink-tan tumor


* [[Necrosis]] and occasional [[hemorrhage]]
* [[Cavitation|Cavitations]]
* Exophytic bronchial growth
|
*Invasive growth pattern
*Peripheral palisading
*Small, monomorphic, cuboidal fusiform
| rowspan="5" |
*[[Chromogranin]]
*[[Synaptophysin]]
*[[CD56]] 
*[[Cytokeratin]]
| rowspan="5" |
* Large, peripheral masses
| rowspan="5" |
* [[Pleura]]
* [[Liver]]
* [[Bone]]
* [[Brain]]
* Abdominal [[Lymph node|lymph nodes]]
* [[Pericardium]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung'''
|
* [[Clear cell|Clear cells]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung'''
|
* Syncytial growth pattern
* [[Eosinophilic]] nucleoli
* [[Lymphocyte|Lymphocytic]] infiltration
* Invasive
* [[Amyloid]] deposition
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype'''
|
* [[Eosinophilic]] [[cytoplasmic]] globules
* Small foci of [[adenocarcinoma]]
* [[Eosinophilic]] inclusions
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type'''
|
* Mixture of:
** [[Adenocarcinoma]]
** [[Squamous cell carcinoma]]
** Giant cell carcinoma
** Spindle cell carcinoma
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Carcinosarcoma'''
| rowspan="5" |
* Accounts for only 0.3-1.3% of all lung malignancies
* Mean age at diagnosis is 60 years
* Tobacco [[smoking]]
* [[Asbestos|Asbestos exposure]]
| rowspan="5" |
* Undifferentiated [[epithelial cells]]
| rowspan="5" |
* Central or peripheral
* Upper lobes
| rowspan="5" |
* > 5 cm
* Well circumscribed
* Grey, yellow or tan creamy, gritty,
* Mucoid and/or [[hemorrhagic]] with significant [[necrosis]]
* [[Sessile]] or [[pedunculated]]
* Infiltrative
|
* Biphasic
* Mixture of [[carcinomatous]] and sarcomatous cells
|
* [[Keratin]]
* [[S-100]]
| rowspan="5" |
* No specific imaging features 
| rowspan="5" |
* Aggressive tumor
* [[Esophagus]], [[jejunum]], and [[rectum]]
* [[Kidney]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma'''
|
* Only spindle shaped tumor cells
* Lymphoplasmacytic infiltrates
| rowspan="3" |
* [[Keratin]]
* EMA
* [[Cytokeratin]]
* [[Vimentin]]
* [[CEA]]
* [[TTF-1]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma'''
|
* Multi- and/or mononucleated tumor [[giant cells]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleomorphic carcinoma'''
|
* Poorly differentiated
* Mixture of [[spindle cells]] and/or [[giant cells]]
* Fibrous or myxoid [[stroma]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma'''
|
* Biphasic
* Mixture of [[Epithelium|epithelial]] and  mesenchymal [[Stromal cell|stroma]]
|
* [[Keratin]]
* EMA
* [[CEA]]
* [[Chromogranin A]]
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid'''
'''Atypical carcinoid'''
|
* Most common in males
* Mean age of diagnosis 45
|
* [[Neuroendocrine cells]] of lung
|
* Typical [[Carcinoid|carcinoids]] are throughout the lungs
* Atypical carcinoid is more commonly peripheral
|
* Firm, well demarcated, tan to yellow tumors
|
* Uniform polygonal cells
* Nuclear atypia
* [[Pleomorphism]]
* The most common patterns are the organoid and trabecular
* Highly vascularized fibrovascular stroma
* Focal [[necrosis]]
|
* [[Cytokeratin]]
* [[Chromogranin]]
* [[Synaptophysin]]
* [[CD57]]
* [[CD56]]
* [[S-100 protein]]
|
* Well defined [[pulmonary]] nodules
* [[Calcification|Calcifications]] is often seen.
* Intense contrast enhancement
|
* [[Liver]]
* [[Bone]]
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]'''
|
* Most patients presents in the third and fourth decade
* Constitutes of less than 1% tumor
* No association with [[cigarette smoking]] or other risk factors
|
* Primitive cells of tracheobronchial origin
|
* Bronchial glands
|
* Ranging in size from 0.5-6 cm
* Soft, polypoid, and pink-tan in colour
* High-grade lesions are infiltrative
|
* Exophytic endobronchial growth
* Surface [[epithelium]] lacking changes of in-situ [[carcinoma]]
* Absence of individual cell [[keratinization]]
* Transitional areas to low grade [[mucoepidermoid carcinoma]]
|
* [[GFAP]]
|
* Well-circumscribed oval or lobulated mass
* [[Calcification|Calcifications]]
* Post-obstructive pneumonic infiltrates
|
* Rare
* [[Liver]]
* [[Bones]]
* [[Adrenal gland]]
* [[Brain]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma'''
|
* Constitutes less than 1% of all lung tumors
* Most commonly seen in fourth and fifth decades of life
|
* Primitive cells of tracheobronchial origin
|
* [[Trachea]]
|
* Gray-white or tan polypoid lesions
* Size ranges from 1–4 cm
* Infiltrative margins
|
* Invades other cell layers
* Heterogeneous cellularity
* Cribriform pattern
* Perineural invasion
|
* [[Immunoperoxidase]]
* [[Cytokeratin]]
* [[Vimentin]]
* [[Actin]]
* [[Calponin]]
* [[S-100 protein]]
* [[p53]]
* [[GFAP]]
|
* Well circumscribed
* Nodule
|
* [[Liver]]
* [[Brain]]
* [[Bone]]
* [[Spleen]]
* [[Kidney]]
* [[Adrenal glands]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma'''
|
* Age ranges from 33 to 71 years
* No association with [[smoking]]
|
*[[Myoepithelial cells]]
|
* Endobronchial
|
* Solid to gelatinous in texture
* White to gray in colour
|
* [[Myoepithelial cells]]
* Dual layer of cells lining ducts
* Low mitotic activity
|
* MNF116
* EMA
* [[SMA]] and [[S-100]]
|
* Reflects [[airway obstruction]]
|
* [[Breast]]
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ'''
| rowspan="3" |
* Most commonly seen in fifth or sixth decades
* Mostly seen in women
|
* Basal cells of squamous epithelium
|
* [[Bronchi]]
|
* Focal or multi-focal plaque-like greyish lesions
* Nonspecific [[erythema]]
* Even nodular or polypoid lesions
|
* [[Goblet cell]] [[hyperplasia]]
* [[Basal cell]] [[hyperplasia]]
* [[Squamous]] [[dysplasia]]
* [[Angiogenic]] [[squamous]] [[dysplasia]]
* Micropapillomatosis
|
* [[EGFR]]
* [[HER2/neu]] 
* [[P53 (protein)|p53]]
* [[MCM2]]
* [[Ki-67]]
* [[Cytokeratin|Cytokeratin 5/6]]
* [[Bcl-2]]
* [[VEGF]]
* Folate binding protein
* [[P16 (gene)|p16]]
|
* Cauliflower like
* Mosaic pattern
| rowspan="3" |
* [[Liver]]
* [[Brain]]
* [[Bone]]
* [[Spleen]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia'''
|
* Surfactant apoprotein
* [[Clara cell secretory protein|Clara cell specific 10kDd protein]]
|
* [[Pleurae|Pleura]]
* Upper lobes
|
* Multiple grey to yellow foci
* 1mm to 10mm in size
|
* Intranuclear inclusions
* [[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]]
* Thickened alveolar walls
* Discontinuous lining of cells
* Moderate atypia
* Pseudopapillae
|
* [[CEA]]
* [[MMP|MMPs]]
* [[E-cadherin]]
* [[Beta-catenin|ß-catenin]]
* [[CD44|CD44v6]]
* [[TTF-1]]
* [[TP53]]
|
* Typically not visualized on [[Radiography|radiographs]]
* Small non-solid nodules
* Ground-glass opacity
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
|
* [[Pulmonary]] [[neuroendocrine cells]]
|
* Endobronchial
|
* Early lesions are:
** Small, gray-white nodules
** Resembling ‘miliary bodies’
* Larger [[carcinoid]] tumors are:
** Firm
** Homogeneous
** Well-defined
** Grey or yellow-white masses
|
* [[Nodular]] aggregates
* [[Myelofibrosis|Fibrosis]] due to [[proliferation]]
* Invade locally
* [[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’.
* [[Carcinoid|Carcinoids]] are tumorlets >5cm.
|
* [[Keratin]]
* [[CEA]]
|
* Mosaic pattern of air trapping
* Sometimes with nodules
* Thickened [[bronchial]] and bronchiolar walls
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
|
* Caucasian
* 80% are women
|
* Endothelial cells
|
* [[Intravascular]]
|
* 0.3-2.0 cm circumscribed mass
* Gray-white or gray-tan firm tissue
* Yellow flecks
* Central [[Calcification|calcifications]]
* Cut surface has a [[cartilaginous]] consistency 
|
* Round to oval-shaped [[nodules]]
* Central [[sclerosis]]
* Hypocellular zone
* Peripheral cellular zone
* [[Calcification|Calcifications]]
* Intranuclear [[cytoplasmic]] [[inclusions]]
|
* [[CD31]]
* [[CD34]]
* [[Factor VIII]] ([[von Willebrand factor]])
* [[Cytokeratin]]
|
* Multiple
* Bilateral
* Small nodules
* 1-2 cm in size
* Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]].
* [[Calcification|Calcifications]]
|
* [[Liver]]
* [[Bone]]
* [[Soft tissue]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma'''
|
* Most common in children
* Median age of diagnosis is 2 years
|
* [[Thoracic]] splanchnopleural [[mesenchyme]]
|
* [[Pleurae|Pleura]]
* [[Lung]]
|
* Purely cystic
* Thin-walled
* Rarely solid
* Firm to gelatinous
* Upto 15 cm
|
* Type I
** Purely [[cystic]]
** Lined by [[respiratory]] type [[epithelium]]
** Underneath [[malignant]] [[cells]]
* Type II
** Partial or complete overgrowth of the septal [[stroma]]
* Type III
** Mixed cells
|
* [[Vimentin]]
* [[S-100 protein]]
|
* Unilateral
* Localized airfilled cysts
* Septal thickening or an intracystic mass
|
* [[Brain]]
* [[Spinal cord]]
* [[Skeletal system]]
* [[Eye|Eyes]]
* [[Pancreas]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma'''
|
* Young women
|
* [[Chondrocyte|Chondrocytes]]
* Cartilaginous cells
|
* Peripheral lesions in [[lung]]
* Primary lesion seen in
** [[Stomach]]
** [[Bone]]
** [[Paraganglia]]
|
* Peripheral
* Solid lesions
* [[Calcified lesion|Calcified]]
|
* Capsulated lobules
* Hypocellular
* Features of [[malignancy]] are absent
|
* N/A
|
* Multiple
* Well circumscribed lesions
* “Pop-corn” calcifications
|
* [[Benign tumor|Benign]] in nature
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor'''
|
* Rare
* Sporadic
* Complicated by
** [[Polyhydramnios]]
** [[Hydrops fetalis|Non-immune hydrops fetalis]]
|
* [[Spindle cells]]
|
* Along the bronchi
|
* 5-10 cm
* Well-circumscribed
* Non-encapsulated
* Smooth or multinodular surface
* The cut surface has a tann-grey to yellow-tan fleshy appearance
* [[Hemorrhage]]
* [[Necrosis]]
|
* [[Fascicles]] of [[spindle cells]]
* [[Bronchial]] invasion
* Peribronchial distribution
* Cystic foci of [[hemorrhage]]
|
* [[Vimentin]]
|
* Well circumscribed
* Opaque hemithorax
* Heterogeneous mass
|
* Rare
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse pulmonary lymphangiomatosis'''
|
* Children
* Young adults of both sexes
|
* [[Smooth muscle cells]] of [[lymphatic vessels]]
|
* Along the [[Lymphatic drainage|lymphatic distribution]]
|
* Prominence of the bronchovascular bundles along
** [[Pleurae|Pleura]]
** Interlobular pulmonary septa
** [[Mediastinum]]
|
* Anastomosing endothelial-lined cells along lymphatic routes
* [[Spindle cells]]
* Intra alveolar siderophages
|
* [[Vimentin]]
|
* Increased interstitial markings
* Thickening of the:
** Interlobular septa
** [[Fissure|Fissures]]
** Central airways
** [[Pleura]]
|
* Skin
* Bone
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Inflammatory myofibroblastic tumor'''
|
* Previous [[viral infections]]
* [[HHV-8|HHV8]]
* Children
|
* [[Myofibroblasts|Myofibroblastic cells]]
|
* Localized to bronchi
|
* Solitary
* Round rubbery masses
* Yellowish-gray discoloration
* Average size of 3.0 cm
* Non-encapculated
* [[Calcification|Calcifications]]
* No local invasion
|
* Mixture of [[spindle cells]]
** [[Fibroblastic]]
** [[Myofibroblasts|Myofibroblastic]]
* Arranged in [[fascicles]]
* Cytologic atypia
* Touton type [[giant cells]]
* [[Plasma cells]]
* [[Lymphoid follicles]]
|
* [[Vimentin]]
* [[Actin]]
* p80
|
* Solitary mass
* Regular borders
* Spiculated appearance
* Accompanied by
** Post-obstructive [[pneumonia]]
** [[Atelectasis]]
|
* Rare
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary artery sarcoma'''
|
* Mean age of diagnosis is 49.3 years
* Commonly misdiagnosed as [[pulmonary embolism]]
|
* [[Mesenchymal cell|Mesenchymal cells]] of the [[intima]]
* Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]]
|
* [[Pulmonary trunk]] most commonly involving:
** [[Right pulmonary artery]]
** [[Left pulmonary artery]]
** [[Pulmonary valve]]
** [[Ventricular outflow tract|Right ventricular outflow tract]]
|
* Mucoid or gelatinous clots filling vascular lumens
* The cut surface may show
** Firm fibrotic areas
** Bony/gritty or chondromyxoid foci
** [[Hemorrhage]] and [[necrosis]] are common in high-grade tumors
|
* Spindle cells in
** A myxoid background
** Collagenized stroma
** Recanalized thrombi
|
* [[Vimentin]]
* [[Osteopontin]]
* [[Factor VIII]]
* [[CD31]]
* [[CD34]]
| rowspan="2" |
* Findings overlap with those of chronic [[thromboembolic disease]]
* Decreased [[vascularity]]
* Heterogeneous [[soft tissue]] density
* Smooth [[vascular]] tapering
|
* [[Lung]] parenchyma
* [[Mediastinum]]
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma'''
|
* Most common in women
* Mean age of diagnosis is 49
|
* [[Smooth muscle]]
|
* [[Pulmonary veins|Pulmonary vein]]
|
* Fleshy-tan tumor
* Can occlude the lumen of the involved vessel
* 3.0- 20.0 cm
* Invasion of wall of the [[vein]]
|
* [[Smooth muscle]] differentiation
* Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]]
* [[Epithelioid]] morphology
|
* [[Vimentin]]
* [[Desmin]]
* [[Actin]]
* [[Keratin]]
|
* N/A
|}
*The table below summarizes the findings that differentiate squamous cell carcinoma of the lung from other conditions that cause  chronic [[cough]], [[weight loss]], [[hemoptysis]], and [[dyspnea]].<ref name="pmid24455507">{{cite journal| author=Bhatt M, Kant S, Bhaskar R| title=Pulmonary tuberculosis as differential diagnosis of lung cancer. | journal=South Asian J Cancer | year= 2012 | volume= 1 | issue= 1 | pages= 36-42 | pmid=24455507 | doi=10.4103/2278-330X.96507 | pmc=PMC3876596 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24455507  }} </ref><ref name="pmid22242302">{{cite journal| author=Kamiya K, Yoshizu A, Misumi Y, Hida N, Okamoto H, Yoshida S| title=[Lung abscess which needed to be distinguished from lung cancer; report of a case]. | journal=Kyobu Geka | year= 2011 | volume= 64 | issue= 13 | pages= 1204-7 | pmid=22242302 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22242302  }} </ref>
{|
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive cough
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight lost
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PFT
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']]
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Parenchyma|'''Parenchyma''']]
| align="center" style="background:#DCDCDC;" + |[[Lung cancer|'''Lung cancer''']]<ref name="pmid21296855">{{cite journal |vauthors=Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D |title=Global cancer statistics |journal=CA Cancer J Clin |volume=61 |issue=2 |pages=69–90 |year=2011 |pmid=21296855 |doi=10.3322/caac.20107 |url=}}</ref><ref name="pmid23649435">{{cite journal |vauthors=Ost DE, Jim Yeung SC, Tanoue LT, Gould MK |title=Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |journal=Chest |volume=143 |issue=5 Suppl |pages=e121S–e141S |year=2013 |pmid=23649435 |pmc=4694609 |doi=10.1378/chest.12-2352 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Years
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +/−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Hoarseness]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Complete blood count]] ([[Complete blood count|CBC]])
*[[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]]
*[[Calcium]]
*[[Alkaline phosphatase]]
*[[Lactate dehydrogenase|LDH]]
*[[Creatinine]]
| style="background:#F5F5F5;" + |
*[[Contrast enhanced CT|Contrast−enhanced CT]] of chest and upper abdomen
| style="background:#F5F5F5;" + |
*Not specific
| style="background:#F5F5F5;" + |
*Tissue [[biopsy]]  (sample should be sufficient for [[Molecule|molecular]] testing)
| style="background:#F5F5F5;" + |
*Risk factor:
**Cigarette smoking
*Types
**[[Small cell lung cancer|Small cell lung cance]]<nowiki/>r ([[Small cell lung cancer|SCLC]])
**[[Non small cell lung cancer|Non−small cell lung cance]]<nowiki/>r ([[Non small cell lung cancer|NSCLC]])
|-
| align="center" style="background:#DCDCDC;" + |'''[[Interstitial lung disease]]'''<ref name="pmid15331185">{{cite journal |vauthors=Lama VN, Martinez FJ |title=Resting and exercise physiology in interstitial lung diseases |journal=Clin. Chest Med. |volume=25 |issue=3 |pages=435–53, v |year=2004 |pmid=15331185 |doi=10.1016/j.ccm.2004.05.005 |url=}}</ref><ref name="pmid15133338">{{cite journal |vauthors=Chetta A, Marangio E, Olivieri D |title=Pulmonary function testing in interstitial lung diseases |journal=Respiration |volume=71 |issue=3 |pages=209–13 |year=2004 |pmid=15133338 |doi=10.1159/000077416 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Rales|Crackles]] or velcro rales
*[[Lung volumes|Inspiratory]] high−pitched [[rhonchi]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Hepatic function test]]
*[[Renal function tests|Renal function test]]
*[[Complete blood count|CBC]]
*[[Serology|Serological testing]]
| style="background:#F5F5F5;" + |
*[[Nodular]], [[reticular]] or both pattern in [[Chest X-ray|chest X−ray]]
*[[Computed tomography|CT]] in patients with diffuse pulmonary lung disease
| style="background:#F5F5F5;" + |
*Reduction in [[Vital capacity|FVC]], [[Residual volume|RV]], [[Functional residual capacity|FRC]], [[Total lung capacity|TLC]] and [[FEV1]] on spirometry
*[[FEV1/FVC ratio|FEV1/FVC]] normal or increase
*[[Lung volumes]]
*Diffusion capacity ([[DLCO]] reduced)
| style="background:#F5F5F5;" + |
*Lung [[biopsy]] when lab, imaging, and PFT has indeterminate result
| style="background:#F5F5F5;" + |
*Clubbing is common in [[asbestosis]] and [[idiopathic pulmonary fibrosis]]
|-
| align="center" style="background:#DCDCDC;" + |'''[[Tuberculosis]] ([[Tuberculosis|TB]])'''<ref name="pmid9332519">{{cite journal |vauthors=Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R |title=Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) |journal=Clin. Infect. Dis. |volume=25 |issue=2 |pages=242–6 |year=1997 |pmid=9332519 |doi= |url=}}</ref><ref name="pmid2456183">{{cite journal |vauthors=Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD |title=Chest roentgenogram in pulmonary tuberculosis. New data on an old test |journal=Chest |volume=94 |issue=2 |pages=316–20 |year=1988 |pmid=2456183 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*More than 2 or 3 weeks
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Pleural effusion]]
*[[Crackles]]
*[[Whispered pectoriloquy]]
*Decreased fremitus
*[[Rhonchi]]
| style="background:#F5F5F5;" + |
*Sputum [[Acid-fast|acid−fast]] bacilli ([[Acid-fast|AFB]]) smear may be positive
*[[Mycobacterium|Mycobacterial]] [[Culture media|culture]] may be positive
*Molecular testing may be helpful
| style="background:#F5F5F5;" + |
*Reactivation of [[Tuberculosis|TB]] is observed as [[Infiltration (medical)|infiltration]] in the upper [[Lobe (anatomy)|lobe]] in [[Chest X-ray|chest X−Ray]]
*In patients with [[Human Immunodeficiency Virus (HIV)|HIV]], Tb is observed as lobar [[Infiltration (medical)|infiltration]], [[adenopathy]], lung mass named [[tuberculoma]], small fibronodular lesions, and/or [[pleural effusion]] on [[Chest X-ray|chest X−Ray]]
*[[Computed tomography|CT]] can detect early nodal process
| style="background:#F5F5F5;" + |
*Decreased [[FEV1]]
*Reduced  [[Vital capacity|FVC]]
| style="background:#F5F5F5;" + |
*Isolation of ''[[Mycobacterium tuberculosis]]'' from some [[secretion]]
| style="background:#F5F5F5;" + |
*Etiology: ''[[Mycobacterium tuberculosis]]''
*Complications: [[Pneumothorax]], [[bronchiectasis]], pulmonary destruction and [[chronic pulmonary aspergillosis]]
|-
| colspan="2" align="center" style="background:#DCDCDC;" + |[[Heart|'''Cardiac''']]
| align="center" style="background:#DCDCDC;" + |[[Pulmonary hypertension|'''Pulmonary hypertension''']]<ref name="pmid21393391">{{cite journal |vauthors=Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG |title=Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry |journal=Chest |volume=140 |issue=1 |pages=19–26 |year=2011 |pmid=21393391 |pmc=3198486 |doi=10.1378/chest.10-1166 |url=}}</ref><ref name="pmid12651053">{{cite journal| author=Sun XG, Hansen JE, Oudiz RJ, Wasserman K| title=Pulmonary function in primary pulmonary hypertension. | journal=J Am Coll Cardiol | year= 2003 | volume= 41 | issue= 6 | pages= 1028-35 | pmid=12651053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12651053  }}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*More than 2 years
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Dysphonia|Hoarseness]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Human Immunodeficiency Virus (HIV)|HIV]] serology
*[[Anti-nuclear antibody|Antinuclear antibody]] ([[Antinuclear antibodies|ANA]])
*[[Rheumatoid factor]] ([[RF]])
*[[Anti-neutrophil cytoplasmic antibody|Anti−neutrophil  cytoplasmic antibody]] ([[Anti-neutrophil cytoplasmic antibody|ANCA]])
| style="background:#F5F5F5;" + |
*Enlargement of the central [[pulmonary artery]] and right heart  in [[Chest X-ray|chest X−Ray]]
*[[Pulmonary  artery]] systolic pressure can be estimated in [[echocardiography]]
| style="background:#F5F5F5;" + |
*Low levels of [[FEV1]]
*Decreased [[Vital capacity|FVC]]
*[[DLCO]] reduced
| style="background:#F5F5F5;" + |
*Mean [[pulmonary artery]] pressure more than 25 [[mmHg]] at rest
| style="background:#F5F5F5;" + |
*[[Chest pain]]
*[[Ascites]]
*[[Syncope]]
*Peripherial [[edema]]
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive cough
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight lost
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PFT
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
| align="center" style="background:#DCDCDC;" rowspan="3" colspan="2" + |'''[[Autoimmune]]'''
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Months
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Hoarseness]]
*[[Stridor]]
*[[Wheeze|Wheezing]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Anti-neutrophil cytoplasmic antibody|ANCA]], [[P-ANCA|P−ANCA]], [[C-ANCA|C−ANCA]]
*[[Blood urea nitrogen|BUN]]
*[[Creatinine]]
*[[Complete blood count]]
*[[Urinalysis]]
*Lung [[biopsy]]
| style="background:#F5F5F5;" + |
*[[Nodules]], [[Lung|pulmonary]] infiltrates, reticular margins, pleural opacities and [[Cavity|cavities]] in [[Chest X-ray|chest X−Ray]]
*[[Nodule (medicine)|Nodules]], [[cavities]] and stellate−shaped peripherial [[pulmonary]] in chest [[Computed tomography|CT]]
*[[Bronchoscopy]] may be helpful
| style="background:#F5F5F5;" + |
*Low levels of [[DLCO]]
*Reduce [[lung volumes]]
| style="background:#F5F5F5;" + |
*Tissue [[biopsy]]
| style="background:#F5F5F5;" + |
*Nasal crusting, sinus pain, chronic [[rhinosinusitis]], nasal obstruction and discharge in [[Upper respiratory tract|upper airway]]
*[[Saddle nose|Saddle nose deformity]]
*[[Purpura]] in lower extremities
|-
| align="center" style="background:#DCDCDC;" + |'''Microscopic polyangitis ([[Microscopic polyangiitis|MPA]])'''<ref name="JennetteFalk1997">{{cite journal|last1=Jennette|first1=J. Charles|last2=Falk|first2=Ronald J.|title=Small-Vessel Vasculitis|journal=New England Journal of Medicine|volume=337|issue=21|year=1997|pages=1512–1523|issn=0028-4793|doi=10.1056/NEJM199711203372106}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Hoarseness]]
*[[Stridor]]
*[[Wheeze|Wheezing]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[ANCA]] positive
*[[Blood urea nitrogen|BUN]]
*[[Creatinine]]
*[[Complete blood count]]
*[[Urinalysis]]
| style="background:#F5F5F5;" + |
*[[Cavitation]], [[Nodule (medicine)|nodules]], and alveolar opacities in [[Chest X-ray|chest X−ray]]
*Head and chest [[Computed tomography|CT]] may be helpful
*[[Electromyography]]/[[nerve conduction study]] may also be helpful
| style="background:#F5F5F5;" + |
*Reduced [[lung volumes]]
| style="background:#F5F5F5;" + |
*Tissue [[biopsy]]
| style="background:#F5F5F5;" + |
*[[Nerve]] damage
*[[Rhinosinusitis]]
*[[Purpura]] involving lower extremities
|-
| align="center" style="background:#DCDCDC;" + |[[Eosinophilic granulomatosis with polyangiitis|'''Churg−Strauss''']]<ref name="pmid23330816">{{cite journal |vauthors=Vaglio A, Buzio C, Zwerina J |title=Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art |journal=Allergy |volume=68 |issue=3 |pages=261–73 |year=2013 |pmid=23330816 |doi=10.1111/all.12088 |url=}}</ref><ref name="pmid6366453">{{cite journal |vauthors=Lanham JG, Elkon KB, Pusey CD, Hughes GR |title=Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome |journal=Medicine (Baltimore) |volume=63 |issue=2 |pages=65–81 |year=1984 |pmid=6366453 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Rales]]
*[[Rhonchi]]
*Expiratory sounds(related to [[asthma]])
| style="background:#F5F5F5;" + |
*Peripherial [[eosinophilia]]
*In active phase [[C-reactive protein|CRP]] and [[Red blood cell|erytrocyte]] [[sedimentation]] rate high
*Elevated [[Immunoglobulin E|IgE]]
*[[Anti-neutrophil cytoplasmic antibody|ANCA]] positive
| style="background:#F5F5F5;" + |
*Infiltrates in [[Chest X-ray|chest X−Ray]]
*Ground glass opacities, tree−in−bud sign and small nodules  in chest [[Computed tomography|CT]]
| style="background:#F5F5F5;" + |
*[[Lung volumes]] decreased
*[[Vital capacity|FVC]] reduced
*[[FEV1/FVC ratio]] <70%
| style="background:#F5F5F5;" + |
*Tissue [[biopsy]]
| style="background:#F5F5F5;" + |
*[[Asthma]]
*[[Eosinophilia]]
*[[Rhinosinusitis]]
|}


==References==
==References==
Line 35: Line 1,335:
[[Category:Lung cancer]]
[[Category:Lung cancer]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Pulmonology]]
[[Category:Surgery]]

Latest revision as of 19:36, 17 October 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

Squamous cell carcinoma of the lung must be differentiated from other diseases that cause chronic cough, weight loss, hemoptysis, and dyspnea among adults such as pulmonary tuberculosis, sarcoidosis, pneumonia, pulmonary fungal infection, and secondary metastases.

Differentiating Squamous Cell Carcinoma of the Lung from other Diseases

The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]

Abrevations:

HPV: human papillomavirus; CEA: Carcino embryogenic antigen; TTF1: Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule;

MMP's: Mettaloprotineases matrix ; GFAP: Glial fibrocilliary acid protein

Benign Lung Tumors[2]
Benign lung tumor Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[3] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[4] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[5]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[6]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma (SCC)[7] Papillary
  • Epithelial cells
  • Central
  • Exophytic
  • Intra-epithelial
  • Without invasion
Clear cell
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[8]
  • Bronchial precursor cell
  • Peripheral
  • White-tan, soft, friable perihilar masses
  • Extensive necrosis
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • Bone marrow
  • Liver
Adenocarcinoma[9][10][11] Acinar adenocarcinoma
  • Columnar cells of bronchioles
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation
  • Lobulated or ill defined edges
  • Irregular-shaped glands
  • Malignant cells:
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
  • Kidney
  • Gastrointestinal Tract
Papillary adenocarcinoma
Bronchio-alveolar carcinoma Non-mucinous
Mucinous
  • Low grade differentiation
  • Composed of:
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
  • Mixed type of cells
  • Low to high grade differentiated cells.
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
Mucinous (“colloid”) carcinoma
Mucinous cystadenocarcinoma
Signet ring adenocarcinoma
  • Focal
  • Cells with nuclei displaced to sides
  • Components of other cells are present.
Clear cell adenocarcinoma
  • Clear cells with no nuclei
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Large cell carcinoma[12] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers
  • Smoking
  • Soft, pink-tan tumor
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
Clear cell carcinoma of the lung
Lymphoepithelioma-like carcinoma of the lung
Large-cell lung carcinoma with rhabdoid phenotype
Mixed type
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Sarcomatoid carcinoma[13] Carcinosarcoma
  • Central or peripheral
  • Upper lobes
  • No specific imaging features 
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
Giant cell carcinoma
Pleomorphic carcinoma
Pulmonary blastoma
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Carcinoid tumor[14] Typical carcinoid

Atypical carcinoid

  • Most common in males
  • Mean age of diagnosis 45
  • Atypical carcinoid is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
Salivary gland tumors[15] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Gray-white or tan polypoid lesions
  • Size ranges from 1–4 cm
  • Infiltrative margins
  • Invades other cell layers
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Well circumscribed
  • Nodule
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association with smoking
  • Endobronchial
  • Solid to gelatinous in texture
  • White to gray in colour
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Preinvasive lesions[16] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Micropapillomatosis
  • Cauliflower like
  • Mosaic pattern
Atypical adenomatous hyperplasia
  • Multiple grey to yellow foci
  • 1mm to 10mm in size
  • Typically not visualized on radiographs
  • Small non-solid nodules
  • Ground-glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Endobronchial
  • Early lesions are:
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are:
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Mesenchymal tumors[17] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women
  • Endothelial cells
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
Chondroma
  • Young women
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
Congenital peribronchial myofibroblastic tumor
  • Along the bronchi
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance
  • Hemorrhage
  • Necrosis
  • Well circumscribed
  • Opaque hemithorax
  • Heterogeneous mass
  • Rare
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Prominence of the bronchovascular bundles along
  • Anastomosing endothelial-lined cells along lymphatic routes
  • Increased interstitial markings
  • Skin
  • Bone
Inflammatory myofibroblastic tumor
  • Localized to bronchi
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non-encapculated
  • Calcifications
  • No local invasion
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
  • Rare
Pulmonary artery sarcoma
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Hemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
Pulmonary vein sarcoma
  • Most common in women
  • Mean age of diagnosis is 49
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel
  • 3.0- 20.0 cm
  • Invasion of wall of the vein
  • N/A
Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Respiratory Parenchyma Lung cancer[20][21] Chronic
  • Years
+ + + +/− + The following investigations may be helpful:
  • Not specific
Interstitial lung disease[22][23] Chronic
  • Variable
+ + + The following investigations may be helpful:
  • Lung biopsy when lab, imaging, and PFT has indeterminate result
Tuberculosis (TB)[24][25] Chronic
  • More than 2 or 3 weeks
+ + + + +
Cardiac Pulmonary hypertension[26][27] Chronic
  • More than 2 years
+ + + The following investigations may be helpful:
Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Autoimmune Wegener's disease (GPA) [28][29] Chronic
  • Months
+ + + + + The following investigations may be helpful:
Microscopic polyangitis (MPA)[30] Chronic
  • Variable
+ + + + + The following investigations may be helpful:
Churg−Strauss[31][32] Chronic
  • Variable
+ + + + +
  • Infiltrates in chest X−Ray
  • Ground glass opacities, tree−in−bud sign and small nodules in chest CT

References

  1. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  2. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  3. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  4. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  5. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  6. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  7. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  8. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  9. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  11. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  12. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  13. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  14. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  15. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  16. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  17. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  18. Bhatt M, Kant S, Bhaskar R (2012). "Pulmonary tuberculosis as differential diagnosis of lung cancer". South Asian J Cancer. 1 (1): 36–42. doi:10.4103/2278-330X.96507. PMC 3876596. PMID 24455507.
  19. Kamiya K, Yoshizu A, Misumi Y, Hida N, Okamoto H, Yoshida S (2011). "[Lung abscess which needed to be distinguished from lung cancer; report of a case]". Kyobu Geka. 64 (13): 1204–7. PMID 22242302.
  20. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". CA Cancer J Clin. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855.
  21. Ost DE, Jim Yeung SC, Tanoue LT, Gould MK (2013). "Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e121S–e141S. doi:10.1378/chest.12-2352. PMC 4694609. PMID 23649435.
  22. Lama VN, Martinez FJ (2004). "Resting and exercise physiology in interstitial lung diseases". Clin. Chest Med. 25 (3): 435–53, v. doi:10.1016/j.ccm.2004.05.005. PMID 15331185.
  23. Chetta A, Marangio E, Olivieri D (2004). "Pulmonary function testing in interstitial lung diseases". Respiration. 71 (3): 209–13. doi:10.1159/000077416. PMID 15133338.
  24. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R (1997). "Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)". Clin. Infect. Dis. 25 (2): 242–6. PMID 9332519.
  25. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988). "Chest roentgenogram in pulmonary tuberculosis. New data on an old test". Chest. 94 (2): 316–20. PMID 2456183.
  26. Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG (2011). "Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry". Chest. 140 (1): 19–26. doi:10.1378/chest.10-1166. PMC 3198486. PMID 21393391.
  27. Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2003). "Pulmonary function in primary pulmonary hypertension". J Am Coll Cardiol. 41 (6): 1028–35. PMID 12651053.
  28. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992). "Wegener granulomatosis: an analysis of 158 patients". Ann. Intern. Med. 116 (6): 488–98. PMID 1739240.
  29. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
  30. Jennette, J. Charles; Falk, Ronald J. (1997). "Small-Vessel Vasculitis". New England Journal of Medicine. 337 (21): 1512–1523. doi:10.1056/NEJM199711203372106. ISSN 0028-4793.
  31. Vaglio A, Buzio C, Zwerina J (2013). "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art". Allergy. 68 (3): 261–73. doi:10.1111/all.12088. PMID 23330816.
  32. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.


Template:WikiDoc Sources